Woman sues over health problems following COVID-19 jab

In what legal experts are calling an unprecedented legal case in Barbados, a female plaintiff has filed a landmark lawsuit against the Barbados government, alleging that she developed life-altering, long-term health complications tied to two doses of the AstraZeneca COVID-19 vaccine she received in 2021. The 2024 claim, which marks the first vaccine injury case of its kind to be heard before the island nation’s Supreme Court, names the Attorney General of Barbados as the official defendant. The plaintiff alleges that the government, which oversaw the country’s national COVID-19 immunization initiative through the Ministry of Health and Wellness, bears legal responsibility for the permanent injuries she attributes to the vaccine.

Represented by one of Barbados’ most respected veteran constitutional lawyers, King’s Counsel Larry Smith, the case centers on the plaintiff’s core allegation that the AstraZeneca vaccine administered to her was defective. Under the island’s Consumer Protection Act, she argues the government failed to deliver a product that met the reasonable safety standards she was legally entitled to expect, opening the state up to liability for her personal harm and all resulting economic and quality-of-life losses.

Court filings reviewed by local media outlet Barbados TODAY outline the timeline of the plaintiff’s illness: she received her first AstraZeneca dose around April 23, 2021, with the second booster dose following in June of that same year. Roughly eight weeks after her second injection, she first noticed an unusual swollen bruise paired with intense pain below her right knee. As additional alarming symptoms emerged—including crippling chest pain and persistent shortness of breath—she sought medical care twice, but on both occasions, treating physicians were unable to identify the root cause of her declining health.

Over time, her condition deteriorated dramatically. Bruising began to spread across her entire body, her breathing difficulties grew more severe, and her energy levels dropped to the point that she could no longer maintain regular daily activity. She was eventually referred to a hematology specialist for specialized testing and assessment, and placed on extended medical leave from work.

As part of the official post-vaccine adverse event protocol, the Pharmacovigilance Team of the Barbados Drug Service launched an investigation into her case, focusing on a suspected adverse reaction tied to the specific batch of her second AstraZeneca dose. Blood samples were analyzed at the Barbados Reference Laboratory, and test results confirmed her symptoms were consistent with vaccine-induced blood clotting. The final official medical assessment classified her condition as a suspected case of vaccine-induced vasculitis, linked directly to the June 25, 2021 AstraZeneca dose.

According to the lawsuit, the plaintiff spent more than a year attempting to resolve the matter outside of court. Between January 2022 and July 2023, she sent five formal letters to the government, notifying officials of her condition and requesting accountability and relief. The government never issued a substantive response to her claims, the suit says. The only correspondence she received came from the Prime Minister’s Office: first, a February 2022 email acknowledging receipt of her initial letter and confirming it had been forwarded to the Chief Medical Officer for follow-up, then a second email in May 2022 stating that her case was under assessment for possible compensation under a previously announced government support mechanism for people experiencing severe vaccine side effects. That correspondence also confirmed the Chief Medical Officer would be in touch shortly with next steps, but the plaintiff says she never received any further update or meaningful action from government officials despite multiple follow-up inquiries. After the pre-action request for compensation sent to the Chief Medical Officer received no response, her legal team moved forward with filing the formal lawsuit.

The suit outlines four key allegations of negligence on the part of the Barbados government: first, that the state failed to establish and activate promised support mechanisms for people experiencing severe vaccine-related complications under the national immunization program; second, that officials failed to respond to the plaintiff’s repeated inquiries about her condition despite having full knowledge of her case; third, that the government made no tangible efforts to remedy her situation or provide the relief she requested; and fourth, that the state failed to uphold a reasonable standard of care for the plaintiff as a participant in the national vaccination program.

Today, the plaintiff continues to live with persistent symptoms: ongoing blood clotting issues, widespread bruising, severe shortness of breath, and chronically reduced energy levels that have entirely eliminated her ability to work full-time. Court documents emphasize that before receiving the vaccine, she enjoyed an active, healthy lifestyle with no pre-existing conditions that would have predicted her current health decline. She is now seeking multiple forms of legal relief: general damages for physical pain, emotional suffering, and loss of quality of life; special damages covering lost earnings and ongoing medical expenses; coverage of all legal fees; six percent annual interest on awarded damages; and any additional relief the Supreme Court deems appropriate for her case.

At present, the matter is in the case management stage of proceedings before the Supreme Court, with no timeline set for a full trial as of yet.